What's breaking now, across thousands of outlets.
DengiAll, India’s first indigenous, single-dose, dengue vaccine is expected to work against all four strains of dengue prevalent in the country. Since the number of dengue cases is generally low in India this year, the clinical trial team might have to wait longer to unblind the study result.
We haven't written up this one. ETHealthworld has the full story — the link below goes straight to it.
Dr Patience Naa Adaku Bortie, Head of Laboratory Services at the GPHA Clinic, has cautioned men against interpreting an elevated prostate-specific antigen (PSA) result as automatic confirmation of prostate cancer.
Kenya has begun construction of the first of 10 Mother and Child hospitals to be built across the country under a KSh4.5 billion initiative by Pan-African business conglomerate Amsons Group. The groundbreaking for the Chebunyo Mother and Child Hospital, a Level 4 facility in Bomet County, was presided over by President William Ruto last…
Katie Craig's son was among the last to be born before the local birthing unit shut down. But after years on bypass, the service has returned.
RESPIRATORY diseases are among Malaysia’s three leading causes of hospital admissions and deaths, with a significant proportion of asthma cases still undiagnosed, prompting the Health Ministry to expand integrated lung care nationwide. Health Ministe...
(RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) said the SERENA-4 Phase III trial of Etcamah or camizestrant in combination with palbociclib did not meet the primary endpoint of progression-free survival in upfront 1st-line advanced ER-positive breast cancer. However a numer
